Therefore, using a panel of three different patient-derived MM cell lines, REN, HMESO and PHI, we further analyzed whether ASA/SA could influence MM growth via targeting HMGB1 in vitro. This evidence concerns the gene HMGB1 and Miyoshi myopathy.